JP2007508273A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007508273A5 JP2007508273A5 JP2006530156A JP2006530156A JP2007508273A5 JP 2007508273 A5 JP2007508273 A5 JP 2007508273A5 JP 2006530156 A JP2006530156 A JP 2006530156A JP 2006530156 A JP2006530156 A JP 2006530156A JP 2007508273 A5 JP2007508273 A5 JP 2007508273A5
- Authority
- JP
- Japan
- Prior art keywords
- derivative
- virus
- polypeptide
- spp
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0323968.8A GB0323968D0 (en) | 2003-10-13 | 2003-10-13 | Immunogenic compositions |
| PCT/EP2004/011621 WO2005039630A2 (en) | 2003-10-13 | 2004-10-11 | Immunogenic compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007508273A JP2007508273A (ja) | 2007-04-05 |
| JP2007508273A5 true JP2007508273A5 (enExample) | 2007-07-19 |
Family
ID=29559207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006530156A Pending JP2007508273A (ja) | 2003-10-13 | 2004-10-11 | 免疫原性組成物 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20070212328A1 (enExample) |
| EP (1) | EP1684802A2 (enExample) |
| JP (1) | JP2007508273A (enExample) |
| KR (1) | KR20060131749A (enExample) |
| CN (1) | CN1893974A (enExample) |
| AU (1) | AU2004283458A1 (enExample) |
| BR (1) | BRPI0415315A (enExample) |
| CA (1) | CA2541693A1 (enExample) |
| CO (1) | CO5700789A2 (enExample) |
| GB (1) | GB0323968D0 (enExample) |
| IL (1) | IL174542A0 (enExample) |
| IS (1) | IS8387A (enExample) |
| MA (1) | MA28106A1 (enExample) |
| NO (1) | NO20061911L (enExample) |
| RU (1) | RU2006111849A (enExample) |
| WO (1) | WO2005039630A2 (enExample) |
| ZA (1) | ZA200602948B (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG172476A1 (en) * | 2002-08-12 | 2011-07-28 | Dynavax Tech Corp | Immunomodulatory compositions comprising a cationic condensing agent, an immunostimulatory compound comprising 5'-cg-3', an a non ionic detergent |
| EP2261244A3 (en) * | 2003-04-15 | 2011-02-23 | Glaxosmithkline LLC | Human il-18 substitution mutants and their conjugates |
| US20100061958A1 (en) * | 2006-09-14 | 2010-03-11 | The Trustees Of The University Of Pennsylvania | Modulation of Regulatory T Cells by Human IL-18 |
| SE532249C2 (sv) * | 2006-11-13 | 2009-11-24 | Theravac Pharmaceuticals Ab | Nya formuleringar av IL-18 för behandling av olika inflammatoriska sjukdomar genom vaccinering |
| CA2687632C (en) | 2007-05-24 | 2013-01-15 | Glaxosmithkline Biologicals S.A. | Lyophilised antigen composition |
| WO2009108235A2 (en) * | 2007-12-07 | 2009-09-03 | Tekmira Pharmaceuticals Corporation | Compositions and methods for modulating immune responses to nucleic acids |
| GB0810869D0 (en) * | 2008-06-13 | 2008-07-23 | Isis Innovation | Vaccine adjuvant composition |
| TWI351288B (en) * | 2008-07-04 | 2011-11-01 | Univ Nat Pingtung Sci & Tech | Cpg dna adjuvant in avian vaccines |
| US9394333B2 (en) | 2008-12-02 | 2016-07-19 | Wave Life Sciences Japan | Method for the synthesis of phosphorus atom modified nucleic acids |
| EP2202298A1 (en) | 2008-12-23 | 2010-06-30 | Stichting Dienst Landbouwkundig Onderzoek | Recombinant classical swine fever virus (CSFV) comprising a modified E2 protein and methods for generating said recombinant CSFV |
| EP2381949B1 (en) * | 2008-12-23 | 2012-11-21 | Intervet International BV | Immunostimulating saponins for use in in situ tumor-destruction therapy |
| WO2010147268A1 (ko) * | 2009-06-19 | 2010-12-23 | 아이진 주식회사 | 자궁경부암 백신 |
| MX342945B (es) | 2009-07-06 | 2016-10-18 | Ontorii Inc * | Profármacos de ácido nucleico novedosos y métodos de uso de los mismos. |
| CN101814489A (zh) * | 2010-03-02 | 2010-08-25 | 晶科电子（广州）有限公司 | 带有功能芯片的发光二极管封装结构及其封装方法 |
| EP2399572A1 (en) | 2010-06-22 | 2011-12-28 | Sandoz AG | Long-term storage of non-glycosylated recombinant human G-CSF |
| US9605019B2 (en) | 2011-07-19 | 2017-03-28 | Wave Life Sciences Ltd. | Methods for the synthesis of functionalized nucleic acids |
| WO2013082503A1 (en) * | 2011-12-01 | 2013-06-06 | Flow Pharma, Inc. | Peptide particle formulation |
| US20140105970A1 (en) * | 2011-12-01 | 2014-04-17 | Flow Pharma, Inc. | Adjuvant and antigen particle formulation |
| SG11201500239VA (en) | 2012-07-13 | 2015-03-30 | Wave Life Sciences Japan | Asymmetric auxiliary group |
| SG11201500243WA (en) * | 2012-07-13 | 2015-04-29 | Shin Nippon Biomedical Lab Ltd | Chiral nucleic acid adjuvant |
| KR20240148947A (ko) | 2012-07-13 | 2024-10-11 | 웨이브 라이프 사이언시스 리미티드 | 키랄 제어 |
| WO2015108048A1 (ja) | 2014-01-15 | 2015-07-23 | 株式会社新日本科学 | 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤 |
| WO2015108047A1 (ja) | 2014-01-15 | 2015-07-23 | 株式会社新日本科学 | 免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤 |
| EP3095460A4 (en) | 2014-01-15 | 2017-08-23 | Shin Nippon Biomedical Laboratories, Ltd. | Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent |
| ES2917473T3 (es) | 2014-01-16 | 2022-07-08 | Wave Life Sciences Ltd | Diseño quiral |
| CN116327912A (zh) * | 2021-12-23 | 2023-06-27 | 上海泽润生物科技有限公司 | 带状疱疹疫苗组合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0930893B1 (en) * | 1996-10-11 | 2005-04-13 | The Regents of The University of California | Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| US6291430B1 (en) * | 1997-09-12 | 2001-09-18 | Ludwig Institute For Cancer Research | Mage-3 peptides presented by HLA class II molecules |
| JP2002510644A (ja) * | 1998-04-03 | 2002-04-09 | ユニバーシティ オブ アイオワ リサーチ ファウンデーション | 免疫治療用オリゴヌクレオチドおよびサイトカインを用いる免疫系刺激のための方法および産物 |
| WO1999056775A1 (en) * | 1998-05-07 | 1999-11-11 | Akzo Nobel N.V. | Use of interleukin-18 as vaccine adjuvant |
| US6562798B1 (en) * | 1998-06-05 | 2003-05-13 | Dynavax Technologies Corp. | Immunostimulatory oligonucleotides with modified bases and methods of use thereof |
| CN1227030C (zh) * | 1999-04-19 | 2005-11-16 | 史密丝克莱恩比彻姆生物有限公司 | 包含皂甙和免疫刺激寡核苷酸的佐剂组合物 |
| US20010044418A1 (en) * | 2000-03-10 | 2001-11-22 | Shoshana Levy | Treatment of allergies |
-
2003
- 2003-10-13 GB GBGB0323968.8A patent/GB0323968D0/en not_active Ceased
-
2004
- 2004-10-11 CA CA002541693A patent/CA2541693A1/en not_active Abandoned
- 2004-10-11 US US10/575,836 patent/US20070212328A1/en not_active Abandoned
- 2004-10-11 WO PCT/EP2004/011621 patent/WO2005039630A2/en not_active Ceased
- 2004-10-11 AU AU2004283458A patent/AU2004283458A1/en not_active Abandoned
- 2004-10-11 CN CNA2004800372174A patent/CN1893974A/zh active Pending
- 2004-10-11 BR BRPI0415315-4A patent/BRPI0415315A/pt not_active Application Discontinuation
- 2004-10-11 JP JP2006530156A patent/JP2007508273A/ja active Pending
- 2004-10-11 EP EP04790466A patent/EP1684802A2/en not_active Withdrawn
- 2004-10-11 KR KR1020067009353A patent/KR20060131749A/ko not_active Withdrawn
- 2004-10-11 RU RU2006111849/14A patent/RU2006111849A/ru not_active Application Discontinuation
-
2006
- 2006-03-23 IL IL174542A patent/IL174542A0/en unknown
- 2006-03-30 IS IS8387A patent/IS8387A/is unknown
- 2006-04-07 CO CO06034534A patent/CO5700789A2/es not_active Application Discontinuation
- 2006-04-11 ZA ZA200602948A patent/ZA200602948B/xx unknown
- 2006-04-25 MA MA28960A patent/MA28106A1/fr unknown
- 2006-04-28 NO NO20061911A patent/NO20061911L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007508273A5 (enExample) | ||
| RU2006111849A (ru) | Иммуногенные композиции | |
| JP2007508272A5 (enExample) | ||
| RU2006111847A (ru) | Вакцинные композиции, содержащие интерлейкин 18 и сапониновую адъювантную систему | |
| Lacaille-Dubois | Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: A review | |
| Lahiri et al. | Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond | |
| AU764969B2 (en) | Vaccines | |
| CN100346829C (zh) | 包含免疫刺激性寡核苷酸和母育酚的佐剂组合物 | |
| JP2014520807A5 (enExample) | ||
| WO1999052549A1 (en) | Adjuvant compositions | |
| AU2002221689A1 (en) | Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocol | |
| JP2007527386A (ja) | 毒性の低いＱｕｉｌＡ画分およびその使用 | |
| JP2006506441A5 (enExample) | ||
| JP2004511527A5 (enExample) | ||
| JP5307859B2 (ja) | ワクチン | |
| US8778356B2 (en) | Vaccine | |
| Arora et al. | Oral mucosal immunization: Recent advancement and future prospects | |
| Acevedo et al. | Adjuvantes: Un componente esencial de las vacunas de Neisseria | |
| Acevedo et al. | Adjuvants: an essential component of neisseria vaccines | |
| Davis et al. | Novel Strategies Using DNA for the Induction of Mucosal Immunity | |
| HK1118481A (en) | Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide | |
| HK1151231A (en) | Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide | |
| HK1079088A (en) | Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |